CorMedix, Inc. (CRMD)
6.925
-0.10
(-1.49%)
USD |
NASDAQ |
Feb 23, 13:06
CorMedix Market Cap : 545.61M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 153.71B |
| Amicus Therapeutics, Inc. | 4.500B |
| Arcutis Biotherapeutics, Inc. | 3.209B |
| ANI Pharmaceuticals, Inc. | 1.712B |
| Castle Biosciences, Inc. | 831.00M |
Market Cap Related Metrics
| PE Ratio | 3.373 |
| PS Ratio | 2.332 |
| Price to Book Value | 1.458 |
| Price to Free Cash Flow | 6.714 |
| Price | 6.925 |
| Earnings Yield | 29.65% |
| Operating PE Ratio | 4.807 |
| Normalized PE Ratio | 3.382 |